US Stock MarketDetailed Quotes

TNDM Tandem Diabetes Care

Watchlist
  • 32.660
  • -1.650-4.81%
Close Dec 13 16:00 ET
  • 32.660
  • 0.0000.00%
Post 20:02 ET
2.14BMarket Cap-16.84P/E (TTM)

Tandem Diabetes Care Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
31.43%243.97M
13.27%221.91M
13.16%191.67M
-6.68%747.72M
-10.75%196.8M
-9.25%185.62M
-2.17%195.92M
-3.71%169.38M
14.00%801.22M
5.00%220.5M
Operating revenue
31.43%243.97M
13.27%221.91M
13.16%191.67M
-6.68%747.72M
-10.75%196.8M
-9.25%185.62M
-2.17%195.92M
-3.71%169.38M
14.00%801.22M
5.00%220.5M
Cost of revenue
24.46%119.32M
15.86%109.12M
12.17%97M
-2.11%380.03M
-1.41%103.5M
-4.25%95.87M
-4.20%94.18M
1.96%86.48M
18.88%388.23M
9.05%104.98M
Gross profit
38.88%124.65M
10.87%112.79M
14.19%94.67M
-10.97%367.69M
-19.24%93.3M
-14.05%89.75M
-0.21%101.74M
-8.99%82.91M
9.77%412.99M
1.58%115.52M
Operating expense
24.28%150.75M
2.15%143.57M
-35.29%136.35M
9.98%522.17M
-3.69%128.36M
0.33%121.3M
23.08%140.54M
97.99%210.72M
34.29%474.8M
31.97%133.28M
Selling and administrative expenses
25.60%99.64M
-3.45%94.24M
0.33%90.11M
5.01%352.5M
-12.22%85.75M
-5.68%79.33M
21.08%97.61M
22.58%89.81M
28.36%335.68M
36.63%97.69M
Research and development costs
21.77%51.11M
14.89%49.33M
-61.75%46.24M
21.96%169.67M
19.72%42.6M
14.06%41.97M
27.89%42.93M
264.63%120.91M
51.12%139.11M
20.66%35.59M
Operating profit
17.28%-26.09M
20.70%-30.77M
67.39%-41.68M
-149.93%-154.48M
-97.47%-35.06M
-91.45%-31.55M
-217.08%-38.81M
-733.34%-127.82M
-372.85%-61.81M
-239.39%-17.76M
Net non-operating interest income expense
326.35%3.48M
-75.33%1.03M
-19.24%3.42M
8,636.84%12.98M
147.36%3.75M
466.67%816K
688.59%4.18M
484.29%4.23M
97.17%-152K
197.12%1.52M
Non-operating interest income
-5.52%5.34M
-51.18%2.82M
-9.39%5.31M
277.38%22.86M
79.36%5.55M
228.84%5.66M
600.24%5.78M
1,313.25%5.87M
798.66%6.06M
6,687.23%3.1M
Non-operating interest expense
-54.93%1.87M
11.71%1.79M
6.22%1.15M
75.40%7.57M
10.94%1.2M
283.86%4.14M
48.89%1.61M
0.00%1.08M
0.00%4.31M
0.00%1.08M
Total other finance cost
----
----
35.25%752K
22.20%2.32M
20.96%606K
40.96%702K
----
26.94%556K
9.79%1.9M
15.17%501K
Other net income (expense)
-1.27M
-154.92%-78.75M
0
-2,128.86%-30.89M
487.50%124K
Gain on sale of security
----
----
----
----
----
----
----
----
110.61%147K
----
Special income (charges)
--0
--0
---1.27M
-153.71%-78.75M
--0
--0
--0
--0
---31.04M
---23K
-Less:Other special charges
----
----
--1.27M
153.71%78.75M
--0
----
----
----
--31.04M
--23K
Income before tax
26.41%-22.61M
14.11%-29.74M
68.01%-39.53M
-137.21%-220.25M
-94.30%-31.31M
35.10%-30.73M
-167.41%-34.63M
-651.79%-123.59M
-683.94%-92.85M
-244.59%-16.11M
Income tax
-71.46%637K
-6.54%1.07M
1,010.10%3.19M
35.30%2.36M
-401.15%-1.31M
37.69%2.23M
-45.58%1.15M
116.65%287K
420.00%1.74M
-177.45%-261K
Net income
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
-707.70%-94.59M
-246.68%-15.85M
Net income continuous Operations
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
-707.70%-94.59M
-246.68%-15.85M
Minority interest income
Net income attributable to the parent company
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
-707.70%-94.59M
-246.68%-15.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.46%-23.25M
13.87%-30.81M
65.52%-42.72M
-135.33%-222.61M
-89.25%-30M
32.69%-32.96M
-137.61%-35.78M
-741.81%-123.87M
-707.70%-94.59M
-246.68%-15.85M
Basic earnings per share
31.37%-0.35
14.55%-0.47
66.15%-0.65
-133.33%-3.43
-84.00%-0.46
32.89%-0.51
-139.13%-0.55
-734.78%-1.92
-688.00%-1.47
-247.06%-0.25
Diluted earnings per share
31.37%-0.35
14.55%-0.47
66.15%-0.65
-133.33%-3.43
-84.00%-0.46
32.89%-0.51
-129.17%-0.55
-734.78%-1.92
-712.50%-1.47
-256.25%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 31.43%243.97M13.27%221.91M13.16%191.67M-6.68%747.72M-10.75%196.8M-9.25%185.62M-2.17%195.92M-3.71%169.38M14.00%801.22M5.00%220.5M
Operating revenue 31.43%243.97M13.27%221.91M13.16%191.67M-6.68%747.72M-10.75%196.8M-9.25%185.62M-2.17%195.92M-3.71%169.38M14.00%801.22M5.00%220.5M
Cost of revenue 24.46%119.32M15.86%109.12M12.17%97M-2.11%380.03M-1.41%103.5M-4.25%95.87M-4.20%94.18M1.96%86.48M18.88%388.23M9.05%104.98M
Gross profit 38.88%124.65M10.87%112.79M14.19%94.67M-10.97%367.69M-19.24%93.3M-14.05%89.75M-0.21%101.74M-8.99%82.91M9.77%412.99M1.58%115.52M
Operating expense 24.28%150.75M2.15%143.57M-35.29%136.35M9.98%522.17M-3.69%128.36M0.33%121.3M23.08%140.54M97.99%210.72M34.29%474.8M31.97%133.28M
Selling and administrative expenses 25.60%99.64M-3.45%94.24M0.33%90.11M5.01%352.5M-12.22%85.75M-5.68%79.33M21.08%97.61M22.58%89.81M28.36%335.68M36.63%97.69M
Research and development costs 21.77%51.11M14.89%49.33M-61.75%46.24M21.96%169.67M19.72%42.6M14.06%41.97M27.89%42.93M264.63%120.91M51.12%139.11M20.66%35.59M
Operating profit 17.28%-26.09M20.70%-30.77M67.39%-41.68M-149.93%-154.48M-97.47%-35.06M-91.45%-31.55M-217.08%-38.81M-733.34%-127.82M-372.85%-61.81M-239.39%-17.76M
Net non-operating interest income expense 326.35%3.48M-75.33%1.03M-19.24%3.42M8,636.84%12.98M147.36%3.75M466.67%816K688.59%4.18M484.29%4.23M97.17%-152K197.12%1.52M
Non-operating interest income -5.52%5.34M-51.18%2.82M-9.39%5.31M277.38%22.86M79.36%5.55M228.84%5.66M600.24%5.78M1,313.25%5.87M798.66%6.06M6,687.23%3.1M
Non-operating interest expense -54.93%1.87M11.71%1.79M6.22%1.15M75.40%7.57M10.94%1.2M283.86%4.14M48.89%1.61M0.00%1.08M0.00%4.31M0.00%1.08M
Total other finance cost --------35.25%752K22.20%2.32M20.96%606K40.96%702K----26.94%556K9.79%1.9M15.17%501K
Other net income (expense) -1.27M-154.92%-78.75M0-2,128.86%-30.89M487.50%124K
Gain on sale of security --------------------------------110.61%147K----
Special income (charges) --0--0---1.27M-153.71%-78.75M--0--0--0--0---31.04M---23K
-Less:Other special charges ----------1.27M153.71%78.75M--0--------------31.04M--23K
Income before tax 26.41%-22.61M14.11%-29.74M68.01%-39.53M-137.21%-220.25M-94.30%-31.31M35.10%-30.73M-167.41%-34.63M-651.79%-123.59M-683.94%-92.85M-244.59%-16.11M
Income tax -71.46%637K-6.54%1.07M1,010.10%3.19M35.30%2.36M-401.15%-1.31M37.69%2.23M-45.58%1.15M116.65%287K420.00%1.74M-177.45%-261K
Net income 29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M-707.70%-94.59M-246.68%-15.85M
Net income continuous Operations 29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M-707.70%-94.59M-246.68%-15.85M
Minority interest income
Net income attributable to the parent company 29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M-707.70%-94.59M-246.68%-15.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.46%-23.25M13.87%-30.81M65.52%-42.72M-135.33%-222.61M-89.25%-30M32.69%-32.96M-137.61%-35.78M-741.81%-123.87M-707.70%-94.59M-246.68%-15.85M
Basic earnings per share 31.37%-0.3514.55%-0.4766.15%-0.65-133.33%-3.43-84.00%-0.4632.89%-0.51-139.13%-0.55-734.78%-1.92-688.00%-1.47-247.06%-0.25
Diluted earnings per share 31.37%-0.3514.55%-0.4766.15%-0.65-133.33%-3.43-84.00%-0.4632.89%-0.51-129.17%-0.55-734.78%-1.92-712.50%-1.47-256.25%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.